For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.
Weill Cornell Medicine scientists target some of the most formidable health challenges of the 21st century, including cancer, cardiovascular disease, metabolic diseases, neurodegenerative diseases such as Parkinson’s and Alzheimer’s, diseases affecting children, and infectious diseases, especially those with significant impact on the developing world.
Dr. Pengbo Zhou (Professor of Pathology and Laboratory Medicine) received a $100,000 WCM COVID-19 Research Grant for his study entitled, "Small molecule G3BP1NTF2 inhibitor rewires G3BP1 to augment its anti-viral activity against SARS-CoV-2."
